Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mdm Garcia Gutierrez"'
Autor:
AB Fernández Román, M García Gil, Mdm Garcia Gutierrez, M Martin Lopez, C. Mariño Martínez, N Herrero Muñoz
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Medication errors in the emergency department can persist throughout the episode of care and up to hospital discharge, leading to inadequate management that can compromise patient care. The pharmacist in an emergency department can be a ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4206b7af4d7a0e23c84b4cbe24992bf
https://doi.org/10.1136/ejhpharm-2019-eahpconf.368
https://doi.org/10.1136/ejhpharm-2019-eahpconf.368
Autor:
AB Fernández Román, N Herrero Muñoz, A Andrés Rosado, C Bravo Lázaro, B Hernández Muniesa, A Ontañón Nasarre, C Mayo López, Mdm Garcia Gutierrez, M García Gil, A Pou Alonso
Publikováno v:
Eur J Hosp Pharm
Background Adalimumab is a monoclonal antibody indicated in immunomediate inflammatory diseases for subcutaneous administration by two different devices: pre-filled syringe and auto-injection pen. Purpose To assess injection-site pain, the ease of us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88bb42cbc69ec4bcea575d2ecd264cf
https://doi.org/10.1136/ejhpharm-2018-eahpconf.246
https://doi.org/10.1136/ejhpharm-2018-eahpconf.246
Autor:
AB Fernández Román, M García Gil, N Herrero Muñoz, J Letellez Fernández, C Bravo Lázaro, C Mayo López, A Andrés Rosado, Mdm Garcia Gutierrez
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Nivolumab (NIV) is a monoclonal antibody for patients with pre-treated advanced nonsquamous non–small-cell lung cancer (NSCLC). It is necessary to evaluate the cost effectiveness of NIV versus docetaxel (DOC), taking into consideration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6abc6ce93cb992732d26fd26bf96f60a
https://doi.org/10.1136/ejhpharm-2018-eahpconf.5
https://doi.org/10.1136/ejhpharm-2018-eahpconf.5